Financials data is unavailable for this security.
View more
Year on year Panacea Biotec Ltd grew revenues 21.57% from 4.60bn to 5.59bn while net income improved from a loss of 332.37m to a smaller loss of 11.73m.
| Gross margin | 60.24% |
|---|---|
| Net profit margin | -5.20% |
| Operating margin | -8.92% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, Panacea Biotec Ltd increased its cash reserves by 18.37%, or 73.22m. Cash Flow from Investing totalled 102.27m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 1.00m for operations while cash used for financing totalled 28.08m.
| Cash flow per share | 1.25 |
|---|---|
| Price/Cash flow per share | 288.27 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
